Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite downsizing, there is movement. Here are some of the latest changes. Recognize anyone?

Celator Pharmaceuticals hired Scott Jackson as its new ceo;
Albireo hired Hans Graffner as chief medical officer;
Fate Therapeutics hired Paul Grayson as ceo and president;
Fate Therapeutics also hired John Mendlein as chairman;
Eurotherm named Steve Blomquist president of Eurotherm USA;
MacroGenics hired Jean-Christophe Tellier as exec vp and chief commercial officer;
MacroGenics hired Jim Karrels as vp and cfo;
Gilead Sciences named ceo John Martin as chairman;
MedImmune appointed Jacqueline Hall as global vp, product development;
MedImmune named Lorin Roskos as vp and global head, pharmacokinetics;
MedImmune hired Erik-Jan Kedder as vp, international regulatory affairs;
MedImmune named named Beth Wensly as vp, project management;
MedImmune hired Reginald Seeto as vp, global strategic marketing and portfolio management;
Sepracor named exec vp Bob Scumaci as cfo to replacer Dave Southwell, who resigned;
Dyax named Mark Sawyer sr vp and head of process sciences;
Medicago named Brigitte Barbeau vp manufacturing;
Rib-X Pharm named Nancy Motola sr vp regulatory affairs;
LifeCycle Pharma named Karin Hamberg exec vp for R&D;
Advaxis hired Christine Chansky as executive clinical officer;
Interleukin Genetics named Eliot Lurier as cfo.